Because depression appears less common in nations where people eat large amounts of fish, scientists have looked into whether fish oils may play a role in mood disorders over the years. Two omega-3 fatty acids —eicosapentaenoic acid (EPA) and docosahexaenoic...
New research done with NBA players found that few take omega-3 supplements and almost all are below the recommended Omega 3 Index of 8% that confers the greatest health benefits.
A diet rich in omega 3 (n-3) fatty acids could reduce the number of headaches in those suffering from migraines, a study states, as researchers points to related molecules that aid in alleviating pain.
Natures Crops International has announced its omega-3 rich Ahiflower plant is now registered and protected under the European and US Plant Variety Protection (PVP) programs.
A final consent degree has been approved between BASF and a second company and the US Federal Trade Commission to settle a case concerning the use of a fish oil supplement in the treatment of non alcoholic fatty liver disease (NAFLD).
FDA and FTC have warned five companies selling dietary supplements over claims their products could help consumers with infertility and pregnancy problems.
Greenland has long been a source of mystery and wonder for the Danish people. One medieval mystery has never been solved, while a more recent one, the story of omega-3 fatty acids, continues to play out in a thriving industry that has fundamentally impacted...
Sam Wiley, CEO of Wiley’s Finest line of omega-3 products, said he’s confident in the course of the category and in the future of the brand as he steps down from a leadership position at the family owned company.
New research has found that over 68% of adults and 95% of children in the United States do not consume enough omega-3s to meet nutritional needs based on the US Dietary Guidelines.
A secondary analysis of a large scale trial whose result has flummoxed experts found that higher blood levels of EPA had no protective effect on cardiovascular health.
A proposed class action that attacks a fish oil supplement over its ethyl ester form has been discounted by industry stakeholders who cite the lawsuit’s flawed factual foundation.
Salmon oil specialists Biomega is to expand operations by investing in a biorefinery in Denmark that will drive salmon peptide production as the firm sets its sights on the human health and nutrition market.
Norwegian biotech firm Hofseth BioCare (HBC) are to partner up with drug delivery specialists Catalent in an agreement that looks to develop a delayed-release formulation of HBC’s OmeGo salmon oil.
